Answers are grounded in this paper and cite their sources.
Examines platelet receptor localization and regulation, highlighting its significance for pharmacological interventions.
Platelet surface glycoprotein (GP) receptors are prime targets for pharmacological interven-tion as they control all principal platelet functions in haemostasis, thrombosis, and thrombo-inflammation. Many of them undergo cellular regulation, such as surface translocation, con-formational changes, internalization or ectodomain shedding, but the underlying mechanisms and their (patho-)physiological significance are in most cases not fully understood. In the first part of this thesis, super-resolution microscopy was established to study platelet receptors on a molecular level. Protocols for single- and two-color direct stochastic optical reconstruction microscopy (dSTORM) were put in place and antibodies against prominent platelet surface GPs were titrated. The resulting single-color images were quantified through cluster-analysis and compared to flow cytometric data on platelet GPs. While these single-color stainings could increase sensitivity in the analysis of expression levels, two-color dSTORM and the development of a neighbor density colocalization analysis enabled investigations into protein interactions close to single molecule resolution. The second part of this thesis unveils the interaction of bridging integrator 2 (BIN2) with stro-mal interaction molecule 1 (STIM1) in the process of platelet Ca2+ signaling. As the major route of Ca2+ influx in platelets, store-operated calcium entry (SOCE) is mediated by STIM1 and triggered by inositol triphosphate receptor (IP3R)-dependent Ca2+ store release. This the-sis confirmed the colocalization and interaction of BIN2 with STIM1 as a Ca2+ signaling modu-lator through the established super-resolution microscopy protocols and colocalization anal-yses. BIN2 deletion led to reduced Ca2+ store release, as well as Ca2+ influx upon induction with agonists, as a result of hindered IP3R function and a defective STIM1-mediated SOCE channel activation. Ca2+ store and inositol-3,4,5-trisphosphate (IP3) production upon agonist stimulation where not affected, highlighting BIN2 as a major component in Ca2+ signaling. As previous studies have shown, endogenous receptor regulation mechanisms can be used to pharmacologically alter platelet function in vivo, as described for targeted downregulation of GPVI or the C-type lectin-like receptor 2 (CLEC-2). Further studies from our group demon-strated that platelets can efficiently “disintegrate” cytoskeleton-connected receptors, specifi-cally β3- and β1-integrins, besides GPVI. So far, we can induce this process artificially by injection of antibodies against the integrin αIIbβ3, effectively removing it from the plasma membrane (PM). It was postulated that this “receptor disintegration” might serve as a basic mechanism to regulate platelet adhesiveness, e.g., during thrombus resolution, providing an interesting target to alter platelet function. In the third part of this thesis the in vivo and in vitro effects of the antibody treatment on platelets and its effects on αIIbβ3 organization on the platelet membrane in stasis were demonstrated. Furthermore, a flow adhesion assay to re-produced “disintegration” in vitro and generate αIIbβ3 enriched tethers in vitro was developed and the established super-resolution microscopy (dSTORM) was used to study this αIIbβ3 regulation on a molecular level and to identify involved intracellular components. With prelimi-nary in vivo data from our laboratory pointing to an involvement of these tethers in inflamma-tion, their interaction with neutrophils was assessed in first experiments.
No takes yet. Share an insight, caveat, or question.
Charly Arne Robert Kusch (2023) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: